---
output: github_document
---

<!-- README.md is generated from README.Rmd. Please edit that file -->

```{r, include = FALSE}
knitr::opts_chunk$set(
  collapse = TRUE,
  comment = "#>",
  fig.path = "man/figures/README-",
  out.width = "100%"
)
set.seed(1)
```

# posologyr [<img src="man/figures/logo_120.png"  align="right" />](https://github.com/levenc/posologyr/)

<!-- badges: start -->
[![R-CMD-check](https://github.com/levenc/posologyr/actions/workflows/R-CMD-check.yaml/badge.svg)](https://github.com/levenc/posologyr/actions/workflows/R-CMD-check.yaml)
[![CRAN status](https://www.r-pkg.org/badges/version/posologyr)](https://CRAN.R-project.org/package=posologyr)
<!-- badges: end -->

## Overview

Determine individual pharmacokinetic (and pharmacokinetic-pharmacodynamic) profiles and use them to personalise drug regimens. You provide the data (observations from
therapeutic drug monitoring, or TDM) and a population pharmacokinetic model, `posologyr` provides the individual a posteriori estimate and allows you to determine the optimal dosing.

`posologyr` provides the following functions for dosage optimization:

+ `poso_dose_conc()` estimates the optimal dose to reach a target concentration at any given time
+ `poso_dose_auc()` estimates the optimal dose to reach a target area under the concentration/time curve (AUC)
+ `poso_time_cmin()` estimates the time needed to reach a target trough concentration (Cmin)
+ `poso_inter_cmin()` estimates the optimal inter-dose interval to reliably achieve a target Cmin between each administration 

Individual pharmacokinetic (PK) profiles can be estimated with or without data from therapeutic drug monitoring (TDM):

+ `poso_estim_map()` computes the Maximum A Posteriori (MAP), aka Empirical Bayes Estimates (EBE), of individual PK parameters from the results of TDM
+ `poso_estim_sir()` estimates the full posterior distributions of individual PK parameters by Sequential Importance Resampling (SIR) from the results of TDM
+ `poso_simu_pop()` samples from the the a priori distributions of PK parameters

`posologyr` takes advantage of the simulation framework provided by the
[rxode2](https://github.com/nlmixr2/rxode2) package.

## Installation

You can install the released version of `posologyr` from
[CRAN](https://CRAN.R-project.org) with:

``` {r eval = FALSE}
install.packages("posologyr")
``` 

You can install the development version of `posologyr` from 
[GitHub](https://github.com/) with:

```{r eval = FALSE}
# install.packages("remotes")
remotes::install_github("levenc/posologyr")
```

## Example of MAP-EBE estimation

`posologyr` allows the adaptation of dosage from two elements: a data set, and 
a prior population PK model.

```{r}
library("posologyr")
```

Data for input into `posologyr` is the same type of data input for rxode2, see 
`vignette("patient_data_input")` for minimal examples.

```{r}
patient_data <- data.frame(ID=1,
                           TIME=c(0.0,1.0,14.0),
                           DV=c(NA,25.0,5.5),
                           AMT=c(2000,0,0),
                           DUR=c(0.5,NA,NA),
                           EVID=c(1,0,0),
                           CLCREAT=80,
                           WT=65)
```

A `posologyr` prior ppk model is a named R list. Its structure is described in `vignette("posologyr_user_defined_models")`.

```{r}
mod_run001 <- list(
ppk_model = rxode2::rxode({
  TVCl = THETA_Cl;
  TVVc = THETA_Vc;
  TVKa = THETA_Ka;

  Cl = TVCl*exp(ETA_Cl);
  Vc = TVVc*exp(ETA_Vc);
  Ka = TVKa*exp(ETA_Ka);

  K20 = Cl/Vc;
  Cc = centr/Vc;

  d/dt(depot) = -Ka*depot;
  d/dt(centr) = Ka*depot - K20*centr;
  d/dt(AUC) = Cc;
}),
error_model = function(f,sigma) {
  dv <- cbind(f,1)
  g <- diag(dv%*%sigma%*%t(dv))
  return(sqrt(g))
},
theta = c(THETA_Cl=4.0, THETA_Vc=70.0, THETA_Ka=1.0),
omega = lotri::lotri({ETA_Cl + ETA_Vc + ETA_Ka ~
    c(0.2,
      0, 0.2,
      0, 0, 0.2)}),
sigma = lotri::lotri({prop + add ~ c(0.05,0.0,0.00)}))
```

With these two elements, one can estimate the patient's MAP-EBE PK parameters,
and the individual concentrations over time.

```{r}
poso_estim_map(patient_data,mod_run001)
```

The individual profile can be plotted easily

```{r map_plot}
patient_001 <- poso_estim_map(patient_data,mod_run001)
plot(patient_001$model,Cc)
```

Using `ggplot2` the observed data points can be added to the plot

```{r map_plot_dv}
# get the observations from the data
indiv_obs           <- patient_data[,c("DV","TIME")]

# set the names to match the names in the rxode2 model
names(indiv_obs)    <- c("value","time")

# call ggplot2
plot(patient_001$model,Cc) +
  ggplot2::geom_point(data=indiv_obs, size= 3, na.rm=TRUE)
```


## Performance of the MAP-EBE algorithm in posologyr
`posologyr` showed comparable performance to NONMEM MAP estimation with option `MAXEVAL=0`:

* Pharmaceutics **2022**, 14(2), 442; [doi:10.3390/pharmaceutics14020442](https://doi.org/10.3390/pharmaceutics14020442)
* Supporting data: [https://github.com/levenc/posologyr-pharmaceutics](https://github.com/levenc/posologyr-pharmaceutics)
